Year archive

Pharma Equity Group A/S — 2024 filings

All 71 regulatory filings released by Pharma Equity Group A/S (BLVIS) in 2024, sourced directly from the official regulator.

71 Filings

2024 Period

2024 filings (71)

Filing	Released	Lang
Regulatory Filings 2024 Regulatory Filings	2024-10-23	English
Regulatory Filings 2024 Regulatory Filings	2024-10-23	Danish
Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has obtained patent protection in Japan for the treatment of colorectal cancer with RNX-051. Regulatory Filings	2024-10-23	Danish
Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has obtained patent protection in Japan for the treatment of colorectal cancer with RNX-051. Regulatory Filings	2024-10-23	Danish
Major Shareholding Notification 2024 Major Shareholding Notification	2024-10-14	Danish
Major Shareholding Notification 2024 Major Shareholding Notification	2024-10-14	English
Major shareholder announcement - Pharma Equity Group A/S Major Shareholding Notification	2024-10-14	Danish
Major shareholder announcement - Pharma Equity Group A/S Major Shareholding Notification	2024-10-14	Danish
Director's Dealing 2024 Director's Dealing	2024-10-14	Danish
Director's Dealing 2024 Director's Dealing	2024-10-14	English
Managers’ transactions Director's Dealing	2024-10-14	Danish
Managers’ transactions Director's Dealing	2024-10-14	English
Share Issue/Capital Change 2024 Share Issue/Capital Change	2024-10-11	English
Capital/Financing Update 2024 Capital/Financing Update	2024-10-11	Danish
Pharma Equity Group announces successful completion of directed issue of new shares Share Issue/Capital Change	2024-10-11	Danish
Pharma Equity Group announces successful completion of directed issue of new shares Share Issue/Capital Change	2024-10-11	Danish
Capital/Financing Update 2024 Capital/Financing Update	2024-10-04	Danish
Share Issue/Capital Change 2024 Share Issue/Capital Change	2024-10-04	English
Pharma Equity Group announces issuance of new shares in a direct issue Share Issue/Capital Change	2024-10-04	Danish
Pharma Equity Group announces issuance of new shares in a direct issue Share Issue/Capital Change	2024-10-04	Danish
Declaration of Voting Results & Voting Rights Announcements 2024 Declaration of Voting Results & Voting Rights Announcements	2024-10-04	Danish
Capital/Financing Update 2024 Capital/Financing Update	2024-10-04	English
Registration of capital reduction by way of a reduction of the nominal value and information on total share capital and number of voting rights Share Issue/Capital Change	2024-10-04	Danish
Registration of capital reduction by way of a reduction of the nominal value and information on total share capital and number of voting rights Share Issue/Capital Change	2024-10-04	English
Interim / Quarterly Report 2024 Interim / Quarterly Report H1 2024	2024-08-16	English
Interim / Quarterly Report 2024 Interim / Quarterly Report H1 2024	2024-08-16	Danish
Consolidated Interim Report 1 January – 30 June 2024 Report Publication Announcement H1 2024	2024-08-16	Danish
Consolidated Interim Report 1 January – 30 June 2024 Regulatory Filings	2024-08-16	Danish
Consolidated Interim Report 1 January – 30 June 2024 Interim / Quarterly Report H1 2024	2024-08-16	English
Consolidated Interim Report 1 January – 30 June 2024 Report Publication Announcement H1 2024	2024-08-16	Danish
Major Shareholding Notification 2024 Major Shareholding Notification	2024-07-15	Danish
Major Shareholding Notification 2024 Major Shareholding Notification	2024-07-15	English
Major shareholder announcement - Pharma Equity Group A/S Major Shareholding Notification	2024-07-15	Danish
Major shareholder announcement - Pharma Equity Group A/S Major Shareholding Notification	2024-07-15	English
Major Shareholding Notification 2024 Major Shareholding Notification	2024-07-15	Danish
Major Shareholding Notification 2024 Major Shareholding Notification	2024-07-15	English
Major shareholder announcement - Pharma Equity Group A/S Major Shareholding Notification	2024-07-15	Danish
Major shareholder announcement - Pharma Equity Group A/S Major Shareholding Notification	2024-07-15	English
Share Issue/Capital Change 2024 Share Issue/Capital Change	2024-05-08	English
Share Issue/Capital Change 2024 Share Issue/Capital Change	2024-05-08	Danish
Exploration of options regarding a directed capital increase at market price in Pharma Equity Group A/S Capital/Financing Update	2024-05-08	Danish
Exploration of options regarding a directed capital increase at market price in Pharma Equity Group A/S Capital/Financing Update	2024-05-08	Danish
Major Shareholding Notification 2024 Major Shareholding Notification	2024-04-23	Danish
Major Shareholding Notification 2024 Major Shareholding Notification	2024-04-23	English
Major shareholder announcement - Pharma Equity Group A/S Major Shareholding Notification	2024-04-23	Danish
Major shareholder announcement - Pharma Equity Group A/S Major Shareholding Notification	2024-04-23	English
Regulatory Filings 2024 Regulatory Filings	2024-04-05	English
Earnings Release 2024 Earnings Release Q2 2024	2024-04-05	Danish
Pharma Equity Group’s subsidiary, Reponex Pharmaceuticals A/S, reports highly positive final results from the phase-2 clinical trial of the company’s patented drug candidate RNX-051. Regulatory Filings	2024-04-05	Danish
Pharma Equity Group’s subsidiary, Reponex Pharmaceuticals A/S, reports highly positive final results from the phase-2 clinical trial of the company’s patented drug candidate RNX-051. Regulatory Filings	2024-04-05	Danish
Annual Report (ESEF) 2023 Annual Report (ESEF) FY 2023	2024-03-20	English
Annual Report (ESEF) 2023 Annual Report (ESEF) FY 2023	2024-03-20	English
Report Publication Announcement 2024 Report Publication Announcement	2024-03-20	Danish
Annual Report 2023 Annual Report FY 2023	2024-03-20	English
Correction: Pharma Equity Group A/S - Annual Report 2023 Annual Report FY 2023	2024-03-20	Danish
Correction: Pharma Equity Group A/S - Annual Report 2023 Report Publication Announcement FY 2023	2024-03-20	English
Correction: Pharma Equity Group A/S - Annual Report 2023 Report Publication Announcement FY 2023	2024-03-20	English
Annual Report 2023 Annual Report FY 2023	2024-03-20	English
Annual Report 2023 Annual Report FY 2023	2024-03-20	English
Pharma Equity Group A/S - Annual Report 2023 Annual Report FY 2023	2024-03-20	Danish
Pharma Equity Group A/S - Annual Report 2023 Report Publication Announcement	2024-03-20	Danish
Pharma Equity Group A/S - Annual Report 2023 Report Publication Announcement FY 2023	2024-03-20	English
Pharma Equity Group A/S - Annual Report 2023 Report Publication Announcement	2024-03-20	English
Regulatory Filings 2024 Regulatory Filings	2024-03-05	Danish
Regulatory Filings 2024 Regulatory Filings	2024-03-05	English
Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has received notification from the European Patent Office (EPO) regarding the decision to grant their patent for drug compositions for pr Regulatory Filings	2024-03-05	Danish
Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has received notification from the European Patent Office (EPO) regarding the decision to grant their patent for drug compositions for pr Regulatory Filings	2024-03-05	English
Legal Proceedings Report 2024 Legal Proceedings Report	2024-01-22	English
Regulatory Filings 2024 Regulatory Filings	2024-01-22	Danish
Notification from the European Patent Office (EPO) regarding the decision to grant their patent for drug compositions aiming to eliminate bacterial promoters of colorectal cancer through intraluminal Regulatory Filings	2024-01-22	Danish
Notification from the European Patent Office (EPO) regarding the decision to grant their patent for drug compositions aiming to eliminate bacterial promoters of colorectal cancer through intraluminal Regulatory Filings	2024-01-22	Danish

Filings by year

2026 10 filings
2025 34 filings
2024 71 filings
2023 58 filings
2022 17 filings
2021 24 filings
2020 10 filings
2019 38 filings
2018 24 filings
2017 26 filings
2016 43 filings
2015 34 filings
2014 56 filings
2013 22 filings
2012 23 filings
2011 29 filings
2010 46 filings
2009 308 filings
2008 505 filings
2007 245 filings